Review Article| Volume 34, ISSUE 3, P595-611, September 2014

Periprocedural Management of Patients on Anticoagulants


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cushman M.
        Epidemiology and risk factors for venous thrombosis.
        Semin Hematol. 2007; 44: 62-69
        • Deitelzweig S.B.
        • Johnson B.H.
        • Lin J.
        • et al.
        Prevalence of clinical venous thromboembolism in the USA: current trends and future projections.
        Am J Hematol. 2011; 86: 217-220
        • Heit J.A.
        The epidemiology of venous thromboembolism in the community.
        Arterioscler Thromb Vasc Biol. 2008; 28: 370-372
        • Go A.S.
        • Hylek E.M.
        • Phillips K.A.
        • et al.
        Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
        JAMA. 2001; 285: 2370-2375
        • Deviri E.
        • Sareli P.
        • Wisenbaugh T.
        • et al.
        Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management.
        J Am Coll Cardiol. 1991; 17: 646-650
        • Douketis J.D.
        • Spyropoulos A.C.
        • Spencer F.A.
        • et al.
        Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e326S-e350S
        • Nematullah A.
        • Alabousi A.
        • Blanas N.
        • et al.
        Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis.
        J Can Dent Assoc. 2009; 75: 41
        • Jamula E.
        • Anderson J.
        • Douketis J.D.
        Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis.
        Thromb Res. 2009; 124: 292-299
        • Mason 3rd, J.O.
        • Gupta S.R.
        • Compton C.J.
        • et al.
        Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
        Ophthalmology. 2011; 118: 543-547
        • Schulman S.
        • Elbazi R.
        • Zondag M.
        • et al.
        Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study.
        Thromb J. 2008; 6: 15
        • White R.H.
        • McKittrick T.
        • Hutchinson R.
        • et al.
        Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.
        Ann Intern Med. 1995; 122: 40-42
        • Spyropoulos A.C.
        • Douketis J.D.
        How I treat anticoagulated patients undergoing an elective procedure or surgery.
        Blood. 2012; 120: 2954-2962
        • Douketis J.D.
        Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”.
        Thromb Haemost. 2012; 108: 210-212
        • Spyropoulos A.C.
        Pro: “Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery”.
        Thromb Haemost. 2012; 108: 213-216
        • Nutescu E.A.
        • Spinler S.A.
        • Wittkowsky A.
        • et al.
        Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
        Ann Pharmacother. 2009; 43: 1064-1083
        • Lip G.Y.
        • Nieuwlaat R.
        • Pisters R.
        • et al.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation.
        Chest. 2010; 137: 263-272
        • Chen J.Y.
        • Zhang A.D.
        • Lu H.Y.
        • et al.
        CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.
        J Geriatr Cardiol. 2013; 10: 258-266
        • Olesen J.B.
        • Lip G.Y.
        • Hansen M.L.
        • et al.
        Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
        BMJ. 2011; 342: d124
        • Heit J.A.
        Risk factors for venous thromboembolism.
        Clin Chest Med. 2003; 24: 1-12
        • Levi M.
        • van der Poll T.
        Two-way interactions between inflammation and coagulation.
        Trends Cardiovasc Med. 2005; 15: 254-259
        • Alfirevic Z.
        • Alfirevic I.
        Hypercoagulable state, pathophysiology, classification and epidemiology.
        Clin Chem Lab Med. 2010; 48: S15-S26
        • Kaatz S.
        • Douketis J.D.
        • Zhou H.
        • et al.
        Risk of stroke after surgery in patients with and without chronic atrial fibrillation.
        J Thromb Haemost. 2010; 8: 884-890
        • Siegal D.
        • Yudin J.
        • Kaatz S.
        • et al.
        Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
        Circulation. 2012; 126: 1630-1639
        • Lip G.Y.
        • Frison L.
        • Halperin J.L.
        • et al.
        Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
        J Am Coll Cardiol. 2011; 57: 173-180
        • Pisters R.
        • Lane D.A.
        • Nieuwlaat R.
        • et al.
        A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
        Chest. 2010; 138: 1093-1100
        • European Heart Rhythm Association
        • European Association for Cardio-Thoracic Surgery
        • Camm A.J.
        • et al.
        Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
        Eur Heart J. 2010; 31: 2369-2429
        • Omran H.
        • Bauersachs R.
        • Rubenacker S.
        • et al.
        The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
        Thromb Haemost. 2012; 108: 65-73
        • Anderson M.A.
        • Ben-Menachem T.
        • Gan S.I.
        • et al.
        Management of antithrombotic agents for endoscopic procedures.
        Gastrointest Endosc. 2009; 70: 1060-1070
        • Wysokinski W.E.
        • McBane R.D.
        • Daniels P.R.
        • et al.
        Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
        Mayo Clin Proc. 2008; 83: 639-645
        • Willard J.E.
        • Lange R.A.
        • Hillis L.D.
        The use of aspirin in ischemic heart disease.
        N Engl J Med. 1992; 327: 175-181
        • CAPRIE Steering Committee
        A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
        Lancet. 1996; 348: 1329-1339
        • Peter K.
        • Myles P.S.
        Perioperative antiplatelet therapy: a knife-edged choice between thrombosis and bleeding still based on consensus rather than evidence.
        Thromb Haemost. 2011; 105: 750-751
        • Hartwig-Otto H.
        Pharmacokinetic considerations of common analgesics and antipyretics.
        Am J Med. 1983; 75: 30-37
        • Gerstein N.S.
        • Schulman P.M.
        • Gerstein W.H.
        • et al.
        Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome.
        Ann Surg. 2012; 255: 811-819
        • Chen T.H.
        • Matyal R.
        The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
        Semin Cardiothorac Vasc Anesth. 2010; 14: 256-273
        • Savonitto S.
        • Caracciolo M.
        • Cattaneo M.
        • et al.
        Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.
        J Thromb Haemost. 2011; 9: 2133-2142
        • Hall R.
        • Mazer C.D.
        Antiplatelet drugs: a review of their pharmacology and management in the perioperative period.
        Anesth Analg. 2011; 112: 292-318
        • Dweck M.R.
        • Cruden N.L.
        Noncardiac surgery in patients with coronary artery stents.
        Arch Intern Med. 2012; 172: 1054-1055
        • Oprea A.D.
        • Popescu W.M.
        ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.
        J Cardiothorac Vasc Anesth. 2013; 27: 779-795
        • Eikelboom J.W.
        • Connolly S.J.
        • Brueckmann M.
        • et al.
        Dabigatran versus warfarin in patients with mechanical heart valves.
        N Engl J Med. 2013; 369: 1206-1214
        • Hylek E.M.
        Dabigatran and mechanical heart valves – not as easy as we hoped.
        N Engl J Med. 2013; 369: 1264-1266
        • Kubitza D.
        • Becka M.
        • Roth A.
        • et al.
        Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects.
        Curr Med Res Opin. 2008; 24: 2757-2765
        • Mueck W.
        • Schwers S.
        • Stampfuss J.
        Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring.
        Thromb J. 2013; 11: 10
        • Stangier J.
        • Rathgen K.
        • Stahle H.
        • et al.
        Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.
        Clin Pharmacokinet. 2010; 49: 259-268
        • Maddox W.
        • Kay G.N.
        • Yamada T.
        • et al.
        Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
        J Cardiovasc Electrophysiol. 2013; 24: 861-865
        • Rowley C.P.
        • Bernard M.L.
        • Brabham W.W.
        • et al.
        Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices.
        Am J Cardiol. 2013; 111: 1165-1168
      1. Xarelto prescribing information. Available at: Accessed January 15, 2014.

      2. Eliquis prescribing information. Available from: Accessed January 15, 2014.

        • Horlocker T.T.
        • Wedel D.J.
        • Rowlingson J.C.
        • et al.
        Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition).
        Reg Anesth Pain Med. 2010; 35: 64-101
        • Green L.
        • Machin S.J.
        Managing anticoagulated patients during neuraxial anaesthesia.
        Br J Haematol. 2010; 149: 195-208
        • Llau J.V.
        • Ferrandis R.
        New anticoagulants and regional anesthesia.
        Curr Opin Anaesthesiol. 2009; 22: 661-666
        • Harrison M.B.
        • Legare F.
        • Graham I.D.
        • et al.
        Adapting clinical practice guidelines to local context and assessing barriers to their use.
        CMAJ. 2010; 182: E78-E84
        • Farias M.
        • Jenkins K.
        • Lock J.
        • et al.
        Standardized clinical assessment and management plans (SCAMPs) provide a better alternative to clinical practice guidelines.
        Health Aff (Millwood). 2013; 32: 911-920